Form 4: Pulmonx Corp General Counsel Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Pulmonx Corp's General Counsel, David Aaron Lehman, sold a total of 5,497 shares of common stock to cover tax obligations related to vesting of restricted stock units.
Summary
- David Aaron Lehman, General Counsel of Pulmonx Corp, sold a total of 5,497 shares of common stock on December 2, 2024.
- The sales were executed in multiple transactions at prices of $6.18 and $6.19 per share.
- These sales were made to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
- The RSUs were granted on June 1, 2021, March 1, 2022, March 1, 2023, and March 1, 2024.
- Following these transactions, Mr. Lehman's direct ownership of Pulmonx Corp common stock decreased to 197,851 shares.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction related to executive compensation. It is neither positive nor negative for the company's outlook.
Risks
- Sales of shares by company insiders can sometimes be perceived negatively by the market, potentially impacting the stock price.
Industry Context
This is a routine transaction related to executive compensation and is common in publicly traded companies. It does not indicate any specific trend or issue within the medical device industry.
Comparison to Industry Standards
- Sales of shares to cover tax obligations are a common practice among executives at publicly traded companies.
- The number of shares sold is relatively small compared to the total outstanding shares of Pulmonx Corp, suggesting it is unlikely to have a significant impact on the stock price.
- Similar transactions are regularly reported by executives at comparable companies in the medical device sector.
Stakeholder Impact
- The share sales may have a minor impact on shareholders due to the small volume of shares sold.
- The transactions do not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 06/01/2021 | Date of the first RSU grant related to the share sales. |
| 03/01/2022 | Date of the second RSU grant related to the share sales. |
| 03/01/2023 | Date of the third RSU grant related to the share sales. |
| 03/01/2024 | Date of the fourth RSU grant related to the share sales. |
| 12/02/2024 | Date of the share sales by David Aaron Lehman. |
| 12/04/2024 | Date the Form 4 was signed. |
Keywords
Pulmonx Corp, insider trading, stock sale, Form 4, David Aaron Lehman, restricted stock units, tax obligations, LUNG
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.